Cell line · CVCL_4358
LL/2 (LLC1)
Cancer cell line, Mus musculus. Malignant tumors of the mouse pulmonary system. 135 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Cite this record
ConductScience Library. LL/2 (LLC1). Cell lines, record CVCL_4358. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_4358
On this page
Cell line
As Cellosaurus gives it.
- Name
- LL/2 (LLC1)
- Accession
- CVCL_4358
- RRID
- RRID:CVCL_4358
- Synonyms
- LL/2 (LLc1), LL/2(LLc1), LL/2, LL2, LLC1, LLC, Lewis lung carcinoma line 1, Lewis lung carcinoma, Lewis Lung Cancer, Lewis-Lung, Lewis Lung
- Species
- Mus musculus (Mouse)
- Category
- Cancer cell line
- Diseases
- Malignant tumors of the mouse pulmonary system (NCIt C21769)
- Derived from
- Lung (in situ)
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems1
| Problem | Cellosaurus's note |
|---|---|
| Caution | Could be identical to 3LL (Cellosaurus=CVCL_5653). |
Source Cellosaurus
Papers135
1 more article gives this line's RRID in its Methods without naming the line nearby, so it is not listed.
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| PubMed 42999416 | Transl Lung Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Integrated Computational Pipeline Combining Metabolomics and Network Pharmacology for Bioactive Scaffold Discovery: Application to Antarctic Moss Chorisodontium aciphyllum. | Chem Biodivers | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Blocking aryl hydrocarbon receptor remodels myeloid-T cell crosstalk and enhances anti-PD-1 response in the tumor microenvironment. | Exp Hematol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Combined HER2-targeted mRNA-LNP vaccine and radiotherapy suppress Lewis lung carcinoma growth in mice: Efficacy and mechanistic insights. | Bioeng Transl Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A Multi-Targeting Chimeric Antigen Receptor-T Cell Platform to Overcome Antigen Heterogeneity in the Treatment of Non-Small Cell Lung Cancer. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| NAPRT loss promotes lung tumor initiation and growth through AKT signaling independently of NAD+ biosynthesis. | Mol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Intravenously deliverable oncolytic virus VET3-TGI favorably alters the tumor microenvironment. | J Immunother Cancer | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Collagen-Binding IL-15 Immunocytokine Armed Oncolytic Adenovirus Establishes a Self-Reinforcing Immunostimulatory Milieu to Potentiate Antitumor Immunity. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| HIF1A+CSF3R+ neutrophils-dominated hypoxic niche induced metabolic reprogramming for neoadjuvant therapy resistance in NSCLC. | J Immunother Cancer | 2026 | Its Methods give the RRID and name the line | PubMed | |
| TNFR1 expression on cancer cells mediates immune escape and an immunosuppressive microenvironment. | J Exp Med | 2026 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 135
See all 135 papersRelatives47
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | EDITGENE Kras (p.G12C) Point Mutation in LLC Cell Line | CVCL_F5YJ | Cell lines | |
| Derived from it | EDITGENE Kras, p.G12C & Trp53, p.R172H Point Mutation in LLC Cell Line | CVCL_F5YK | Cell lines | |
| Derived from it | EDITGENE LLC-CopGFP | CVCL_F6C8 | Cell lines | |
| Derived from it | EDITGENE LLC-FLUC | CVCL_F5UR | Cell lines | |
| Derived from it | EDITGENE Trp53 (p.R172H) Point Mutation in LLC Cell Line | CVCL_F5YL | Cell lines | |
| Derived from it | Genomeditech LLC1 H_SLC39A6 | CVCL_E6W9 | Cell lines | |
| Derived from it | HyCyte LL/2 (LLC1) KO-mArg2 | CVCL_F1R8 | Cell lines | |
| Derived from it | HyCyte LL/2 (LLC1) KO-mChchd10 | CVCL_F4JI | Cell lines | |
| Derived from it | HyCyte LL/2 (LLC1) KO-mIrf7 | CVCL_E1LR | Cell lines | |
| Derived from it | HyCyte LL/2 (LLC1) KO-mItgal | CVCL_F1R9 | Cell lines |
1 to 10 of 47
See all 47 relativesCell banks16
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ATCC | CRL-1642 | ATCC | |
| AddexBio | C0016030/5000 | Cellosaurus | |
| BCRC | 60050 | BCRC | |
| BCRJ | 0145 | BCRJ | |
| CLS | 305311 | CLS | |
| CLS | 400263 | Discontinued | Cellosaurus |
| ECACC | 90020104 | ECACC | |
| EDITGENE | EDC00260 | EDITGENE | |
| Hysigen | TCM-C742 | Hysigen | |
| IZSLER | BS TCL 216 | Cellosaurus |
1 to 10 of 16
See all 16 cell banksData dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_4358
GET https://conductscience.org/api/cell-lines/v1/CVCL_4358/papers?page=2